Share & more
A generic 3-in-1 anti-AIDS pill, recently approved by the US Food and Drug Administration (FDA), could greatly ease daily treatment regimens for patients in developing countries, a senior US official said on Wednesday.
Although it was not yet clear how cost-effective the new drug would be, HIV-positive people would take only one pill twice a day, which "should facilitate better therapies and better adherence", The New York Times quoted acting US Global AIDS Coordinator Mark Dybul as saying.
The fixed-dose combination tablet, manufactured by Aurobindo Pharma, an Indian generic drug company, will be available for purchase and distribution under the President's Emergency Plan for AIDS Relief (PEPFAR).
PEPFAR is a $15 billion initiative, launched by US President George W. Bush in 2003, for the prevention, treatment and care of HIV/AIDS in 12 African countries and the Caribbean.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions